A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both ...

A McGill University study of more than 450,000 patients found that incretin-based Type 2 diabetes drugs, including GLP-1 receptor agonists and DPP-4 inhibitors, were associated with a lower risk of ...

The research has generated significant interest from firms in food & supplements as consumers seek natural alternatives to GLP-1 drugs.

In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists ...

Almost ten years after Sir Anthony Colman ­completed his report into the collapse of CL Financial, and 15 years after the commission of enquiry started, Director of Public Prosecutions Roger Gaspard ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $226.22, with a ...

According to the 2026 American Diabetes Association (ADA) Standards of Medical Care, oral antidiabetic drug (OAD) therapy (typically with MET) can be initiated concurrent with lifestyle intervention ...

Good afternoon, and welcome to Omeros Corporation's conference call. Today's call is being recorded at the company's request, and a replay will be available on the Omeros website. I'll now turn the ...

DUBLIN and BRIDGEWATER, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today commented on recent ...